Management of a Pediatric Patient on the Berlin Heart Excor Ventricular Assist Device With Argatroban After Heparin-Induced Thrombocytopenia

ASAIO Journal ◽  
2008 ◽  
Vol 54 (5) ◽  
pp. 546-547 ◽  
Author(s):  
Michael L. Schmitz ◽  
Patti Massicotte ◽  
Sherry C. Faulkner ◽  
Adnan T. Bhutta ◽  
Charles E. Johnson ◽  
...  
Keyword(s):  
Pediatric Patient ◽  
Ventricular Assist Device ◽  
Assist Device ◽  
Ventricular Assist ◽  
Heparin Induced Thrombocytopenia ◽  
Berlin Heart

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient

2016 ◽  
Vol 102 (2) ◽  
pp. e129-e130 ◽  
Author(s):  
Arianna Di Molfetta ◽  
Sergio Filippelli ◽  
Gianfranco Ferrari ◽  
Aurelio Secinaro ◽  
Krystzof Zielinski ◽  
...  
Keyword(s):  
Pediatric Patient ◽  
Ventricular Assist Device ◽  
Assist Device ◽  
Ventricular Assist ◽  
Membrane Rupture ◽  
Berlin Heart ◽  
Multilayer Membrane

scholarly journals Post-transplant Outcomes of Children Bridged to Transplant With the Berlin Heart EXCOR Pediatric Ventricular Assist Device

Circulation ◽  
2013 ◽  
Vol 128 (11_suppl_1) ◽  
pp. S24-S31 ◽  
Author(s):  
P. Eghtesady ◽  
C. S. D. Almond ◽  
C. Tjossem ◽  
D. Epstein ◽  
M. Imamura ◽  
...  
Keyword(s):  
Ventricular Assist Device ◽  
Assist Device ◽  
Ventricular Assist ◽  
Post Transplant ◽  
Transplant Outcomes ◽  
Berlin Heart

First Successful Organ Procurement From a Pediatric Patient With a Nonpulsatile Ventricular Assist Device

2021 ◽  
Author(s):  
Pınar Yazıcı Özkaya ◽  
Eşe Eda Turanlı ◽  
Hamdi Metin ◽  
Hatice Feray Arı ◽  
Osman Nuri Tuncer ◽  
...  
Keyword(s):  
Pediatric Patient ◽  
Ventricular Assist Device ◽  
Organ Procurement ◽  
Assist Device ◽  
Ventricular Assist

Successful Bridge to Transplant Using the Berlin Heart Left Ventricular Assist Device in a 3-Month-Old Infant

2006 ◽  
Vol 81 (3) ◽  
pp. 1116-1118 ◽  
Author(s):  
Gansevoort H. Dunnington ◽  
Justin Sleasman ◽  
Abdulaziz Alkhaldi ◽  
Marc P. Pelletier ◽  
Bruce A. Reitz ◽  
...  
Keyword(s):  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Left Ventricular ◽  
Assist Device ◽  
Ventricular Assist ◽  
Bridge To Transplant ◽  
Berlin Heart ◽  
Left Ventricular Assist

Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device

2020 ◽  
Vol 109 (6) ◽  
pp. e439-e440 ◽  
Author(s):  
Salvador R. Maffei ◽  
Harveen K. Lamba ◽  
Cassius Kwasi Mensah ◽  
Arthur Bracey ◽  
Andrew Civitello ◽  
...  
Keyword(s):  
Ventricular Assist Device ◽  
Assist Device ◽  
Ventricular Assist ◽  
Heparin Induced Thrombocytopenia

Use of Systemic Bivalirudin and an Anticoagulant-Free Purge Solution in a Percutaneous Left Ventricular Assist Device in a Patient With Heparin-Induced Thrombocytopenia

2020 ◽  
pp. 089719002093053 ◽  
Author(s):  
Hasan Kazmi ◽  
Ashley E. Milkovits
Keyword(s):  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Severe Aortic Stenosis ◽  
Left Ventricular ◽  
Assist Device ◽  
Ventricular Assist ◽  
Heparin Induced Thrombocytopenia ◽  
Cardiac Catheterization Laboratory ◽  
Left Ventricular Assist ◽  
History Of

The use of systemic bivalirudin and an anticoagulant-free purge solution in a percutaneous left ventricular assist device (pVAD) is described in a patient with a history of heparin-induced thrombocytopenia (HIT). An 80-year-old man with a past medical history of severe aortic stenosis and HIT was transferred to our facility for cardiogenic shock. The patient was emergently taken to the cardiac catheterization laboratory for balloon valvuloplasty and Impella pVAD (Abiomed, Inc) implantation. Due to the history of HIT, bivalirudin was chosen as an alternative anticoagulant. The device representative suggested adding bivalirudin 20 mg/500 mL to the Impella purge solution. However, due to the negligible amount of bivalirudin this would provide in comparison to patient’s systemic intravenous bivalirudin dose, we elected not to add bivalirudin to the purge solution. The patient remained on the Impella for 72 hours with intravenous bivalirudin without any evidence of pump thrombosis as evidenced by unchanging flows and stable purge pressures. Unfortunately, despite functional Impella pVAD support, care was withdrawn due to ongoing multi-organ failure. This patient case demonstrated the safe, effective, and practical use of an anticoagulant-free purge solution with systemic bivalirudin in a patient with 72 hours of Impella support.

Sign in / Sign up

Export Citation Format

Share Document